Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial alterations in hypercholesterolemia: more than simply vasodilator dysfunction

P S Tsao1, J P Cooke

  • 1Division of Cardiovascular Medicine, Stanford University School of Medicine, California 94305-5406, USA.

Journal of Cardiovascular Pharmacology
|January 12, 1999
PubMed
Summary

Endothelial dysfunction in vascular disease involves reduced nitric oxide (NO) activity, partly due to elevated ADMA levels. L-arginine supplementation may counteract these effects, offering potential therapeutic strategies for atherosclerosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Health, Inflammation, and Cardiometabolic Factors in the VA Million Veteran Program.

JDR clinical and translational research·2024
Same author

Guest Editor John Cooke Lends Expertise on Special Cardiovascular Regeneration Issue.

Methodist DeBakey cardiovascular journal·2015
Same author

Fatal herpes simplex virus hepatitis following neoadjuvant chemoradiotherapy and anterior resection for rectal cancer.

Annals of the Royal College of Surgeons of England·2014
Same author

Guest editors Paolo Decuzzi & John P. Cooke lend expertise on special regenerative medicine issue.

Methodist DeBakey cardiovascular journal·2013
Same author

Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts.

Current medical research and opinion·2012
Same author

Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

Clinical pharmacology and therapeutics·2011

Area of Science:

  • Cardiovascular Research
  • Endothelial Biology
  • Metabolic Disorders

Background:

  • Occlusive vascular disease originates from endothelial dysfunction, marked by diminished nitric oxide (NO) activity.
  • NO plays a crucial role in inhibiting atherogenesis by regulating monocyte adherence, platelet activation, and smooth muscle proliferation.
  • Reduced NO activity in hypercholesterolemia and metabolic disorders is multifactorial, involving free radicals, NO synthase alterations, and endogenous inhibitors like ADMA.

Purpose of the Study:

  • To investigate the mechanisms underlying reduced nitric oxide (NO) activity in endothelial dysfunction.
  • To explore the role of asymmetric dimethylarginine (ADMA) in hypercholesterolemia and its association with impaired NO-mediated vasodilation.
  • To evaluate the potential of L-arginine in counteracting the adverse effects of ADMA.

Related Experiment Videos

Main Methods:

  • Analysis of factors contributing to decreased NO activity in metabolic disorders.
  • Measurement of plasma ADMA concentrations in hypercholesterolemic humans.
  • Assessment of endothelium-dependent vasodilation and urinary nitrate excretion.
  • Evaluation of the effects of L-arginine administration.

Main Results:

  • Plasma ADMA concentrations are elevated in hypercholesterolemic individuals.
  • Elevated ADMA is linked to impaired NO-mediated vasodilation and reduced urinary nitrate excretion.
  • Administration of the NO precursor L-arginine counteracted the negative effects associated with ADMA.

Conclusions:

  • Asymmetric dimethylarginine (ADMA) contributes significantly to endothelial dysfunction in hypercholesterolemia.
  • Elevated ADMA levels impair nitric oxide (NO) bioavailability and vasodilation.
  • L-arginine shows promise in mitigating ADMA-induced endothelial dysfunction, suggesting potential therapeutic avenues for atherosclerosis.